NCT06866405

A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2025-04-16Est. Completion: 2028-02-24

Enrollment target: 550 participants

Locations

Center for Research in Women's Health, Birmingham, Alabama, United States
Children's of Alabama, Birmingham, Alabama, United States
University of Alabama at Birmingham - School of Medicine, Birmingham, Alabama, United States
University of Alabama at Birmingham Women & Infants Center, Birmingham, Alabama, United States
USA Health Children's and Women's Hospital, Mobile, Alabama, United States
USA Health Strada Patient Care Center, Mobile, Alabama, United States
Ronald Reagan UCLA Medical Center, Los Angeles, California, United States
Ronald Reagan UCLA Medical Center (inpatient hospital), Los Angeles, California, United States
Ronald Reagan UCLA Medical Center, Los Angeles, California, United States
UCLA (outpatient clinic), Los Angeles, California, United States
UCLA Clinical and Translational Research Center (research clinic), Los Angeles, California, United States
UCLA, Los Angeles, California, United States
Lucile Packard Children's Hospital-Labor and Delivery Unit, Palo Alto, California, United States
Stanford Obstetrics Clinic, Palo Alto, California, United States

SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus InfectionsRespiratory Distress SyndromeSystemic Inflammatory Response Syndrome

The purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of two doses (dose A and dose B)…

Alcalá de Henares, SpainEst. completion Oct 2, 2026

Acute Respiratory Infections (ARIs)

This is a prospective, observational, multicenter study employing continuous, convenience sampling, stratified by study …

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.